Vaxcyte, Inc. — Director's Dealing 2020

Jun 12, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2020-06-11

Reporting Person: Hirth Peter (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	7113	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$1.29	2026-09-15	Common Stock (29638)		Indirect
Stock Option (right to buy)	$2.03	2028-07-23	Common Stock (23605)		Direct
Stock Option (right to buy)	$5.35	2030-04-17	Common Stock (18590)		Direct

Footnotes

F1: The shares subject to the option are fully vested and exercisable.

F2: 1/3 of the shares subject to the option vested on July 24, 2019, and 1/36 of the shares vest monthly thereafter.

F3: 1/3 of the shares subject to the option vest on March 20, 2021, and 1/36 of the shares vest monthly thereafter.